TherapeuticsMD | 10-K/A: Annual report (Amendment)
05:05
TherapeuticsMD | 10-K: Annual report
Mar 30 04:35
TherapeuticsMD | 8-K: Current report
Mar 30 04:33
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Walker Marlan D
Dec 8, 2023 05:51
TherapeuticsMD | 144: Notice of proposed sale of securities pursuant to Rule 144
Dec 7, 2023 00:36
TherapeuticsMD | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(25.73%),David Rosen(25.73%)
Nov 17, 2023 22:28
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Rubric Capital Management LP
Nov 17, 2023 22:27
TherapeuticsMD: Q3 2023 Earnings Report
Nov 15, 2023 05:31
TherapeuticsMD | 8-K: TherapeuticsMD Announces Third Quarter 2023 Financial Results
Nov 15, 2023 05:25
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Officer ZIEGLER JOSEPH
Aug 22, 2023 04:22
TherapeuticsMD | 3: Initial statement of beneficial ownership of securities-Officer ZIEGLER JOSEPH
Aug 22, 2023 04:20
TherapeuticsMD | 8-K: Current report
Aug 19, 2023 05:18
TherapeuticsMD | 10-Q: Q2 2023 Earnings Report
Aug 14, 2023 19:30
TherapeuticsMD | 8-K: TherapeuticsMD Announces Second Quarter 2023 Financial Results
Aug 14, 2023 19:15
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Thompson Tommy G
Jul 20, 2023 05:29
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Naughton Gail K
Jul 20, 2023 05:28
TherapeuticsMD | 4: Statement of changes in beneficial ownership of securities-Director Collins Cooper C.
Jul 20, 2023 05:27
TherapeuticsMD | D: Filing D
Jul 11, 2023 05:49
TherapeuticsMD | 8-K: Current report
Jul 11, 2023 05:20
TherapeuticsMD | 8-K: Current report
Jul 7, 2023 04:38
No Data
No Data